Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study.

MLA

Iwase, Akira, et al. “Oral Progestogen versus Intramuscular Progesterone for Luteal Support after Assisted Reproductive Technology Treatment: A Prospective Randomized Study.” Archives of Gynecology and Obstetrics, vol. 277, no. 4, Apr. 2008, pp. 319–24. EBSCOhost, https://doi.org/10.1007/s00404-007-0484-4.

APA

Iwase, A., Ando, H., Toda, S., Ishimatsu, S., Harata, T., Kurotsuchi, S., Shimomura, Y., Goto, M., & Kikkawa, F. (2008). Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study. Archives of Gynecology and Obstetrics, 277(4), 319–324. https://doi.org/10.1007/s00404-007-0484-4

Chicago

Iwase, Akira, Hisao Ando, Shigeru Toda, Shino Ishimatsu, Toko Harata, Shozo Kurotsuchi, Yuji Shimomura, Maki Goto, and Fumitaka Kikkawa. 2008. “Oral Progestogen versus Intramuscular Progesterone for Luteal Support after Assisted Reproductive Technology Treatment: A Prospective Randomized Study.” Archives of Gynecology and Obstetrics 277 (4): 319–24. doi:10.1007/s00404-007-0484-4.